GVHD Product Launched In Japan
Filed with ASX · · 2 pages · English
Story so far
Earlier from Mesoblast
- Increased Survival Using MSB Cells In Children With aGVHD
- Half Yearly Report and Accounts (including Appendix 4D)
- MSB Therapy Shows Benefit In First Cohort Of RA Patients
- Phase 3 Heart Failure Trial Size Substantially Reduced
- US Govt Grants for Further Development of Stem Cell Products
Later from Mesoblast
- Key US Patent Granted For Treatment Of Rheumatoid Arthritis
- Circulation Publishes Improved Outcomes with Mesoblast Cells
- Mesoblast Receives $5.05m for Stem Cell Pipeline Development
- MSB Accelerates Plans for Commercial Manufacturing Operation
- MSB & NIH Agree 120 Patient Trial In End-Stage Heart Failure
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast